Literature DB >> 16115185

HIV and hepatitis C co-infection.

R Jones1, J Dunning, M Nelson.   

Abstract

HIV/HCV co-infection is emerging as a major cause of morbidity and mortality in the 21st century. This editorial reviews the prevalence of co-infection, the factors involved in acquisition of HCV, and the influence of co-infection on disease progression. We examine the results of the major co-infection trials including APRICOT, ACTG 5071 and RIBAVIC. These trials, in association with emerging evidence for future therapies currently undergoing investigation, have led to increased hope of treatment success in co-infected individuals.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16115185     DOI： 10.1111/j.1742-1241.2005.00596.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN： 1368-5031            Impact factor:   2.503


  12 in total

1.  Substance Abuse, Hepatitis C, and Aging in HIV: Common Cofactors that Contribute to Neurobehavioral Disturbances.

Authors:  Randi Melissa Schuster; Raul Gonzalez
Journal:  Neurobehav HIV Med       Date:  2012-02-16

2.  Dual inhibition of HCV and HIV by ring-expanded nucleosides containing the 5:7-fused imidazo[4,5-e][1,3]diazepine ring system. In vitro results and implications.

Authors:  Ning Zhang; Peng Zhang; Andrea Baier; Lucyna Cova; Ramachandra S Hosmane
Journal:  Bioorg Med Chem Lett       Date:  2014-01-08       Impact factor: 2.823

3.  Hepatitis C virus core protein induces neuroimmune activation and potentiates Human Immunodeficiency Virus-1 neurotoxicity.

Authors:  Pornpun Vivithanaporn; Ferdinand Maingat; Liang-Tzung Lin; Hong Na; Christopher D Richardson; Babita Agrawal; Eric A Cohen; Jack H Jhamandas; Christopher Power
Journal:  PLoS One       Date:  2010-09-21       Impact factor: 3.240

4.  Treatment, care and support for people co-infected with HIV and hepatitis C: a scoping review.

Authors:  Michael G Wilson; Melisa Dickie; Curtis L Cooper; Adriana Carvalhal; Jean Bacon; Sean B Rourke
Journal:  Open Med       Date:  2009-10-06

5.  Risk Factors and Seroprevalence of Hepatitis C among Patients Hospitalized at Mulago Hospital, Uganda.

Authors:  J I O'Reilly; P Ocama; C K Opio; A Alfred; E Paintsil; E Seremba; A N Sofair
Journal:  J Trop Med       Date:  2011-08-09

6.  Social determinants of health associated with hepatitis C co-infection among people living with HIV: results from the Positive Spaces, Healthy Places study.

Authors:  Sean B Rourke; Michael Sobota; Ruthann Tucker; Tsegaye Bekele; Katherine Gibson; Saara Greene; Colleen Price; J J Jay Koornstra; Laverne Monette; Steve Byers; James Watson; Stephen W Hwang; Dale Guenter; James Dunn; Amrita Ahluwalia; Michael G Wilson; Jean Bacon
Journal:  Open Med       Date:  2011-07-05

7.  The case of Scott Ortiz: a clash between criminal justice and public health.

Authors:  Homer D Venters; Asiya M Razvi; Maria S Tobia; Ernest Drucker
Journal:  Harm Reduct J       Date:  2006-07-24

8.  Effects of Angiotensin Converting Enzyme Inhibitors on Liver Fibrosis in HIV and Hepatitis C Coinfection.

Authors:  Lindsey J Reese; Diane S Tider; Alicia C Stivala; Dawn A Fishbein
Journal:  AIDS Res Treat       Date:  2012-11-01

9.  The simultaneous presence and expression of human hepatitis C virus (HCV), human herpesvirus-6 (HHV-6), and human immunodeficiency virus-1 (HIV-1) in a single human T-cell.

Authors:  S Zaki Salahuddin; Katherine A Snyder; Andre Godwin; Renu Grewal; John G Prichard; Ann S Kelley; Dennis Revie
Journal:  Virol J       Date:  2007-10-24       Impact factor: 4.099

10.  Hepatitis B and/or C co-infection in HIV infected patients: a study in a tertiary care centre from South India.

Authors:  Naval Chandra; Nayana Joshi; Y S N Raju; Ajit Kumar; Vijay D Teja
Journal:  Indian J Med Res       Date:  2013-12       Impact factor: 2.375
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.